20935 ⎘
De novo binding domain containing polypeptides and uses thereof
#2H3.3 CTL peptides and uses thereof
#3Peptides and combination of peptides for use in immunotherapy against small cell lung cancer and other cancers
#4Peptides and combination of peptides for use in immunotherapy against small cell lung cancer and other cancers
#5Peptide derived from GPC3, pharmaceutical composition for treatment or prevention of cancer using same, immunity inducer, and method for producing antigen-presenting cells
#6Methods and compositions for the prevention and treatment of surgical adhesions
#7Peptides, combination of peptides as targets and for use in immunotherapy against gallbladder cancer and cholangiocarcinoma and other cancers
#8De novo binding domain containing polypeptides and uses thereof
#9De novo binding domain containing polypeptides and uses thereof
#10Antibody to human and mouse SEMA3A and use thereof
#11Checkpoint regulator antagonists
#12HSP70-derived peptide, pharmaceutical composition for treating or preventing cancer using same, immunity inducer, and method for producing antigen presenting cell
#13Oral cancer vaccine
#14Prostate specific membrane antigen binding protein
#15T cell receptors and immune therapy using the same
#16A Novel Complex Comprising A Cell Penetrating Peptide, A Cargo And A TLR Peptide Agonist
#17DENDRITIC CELL IMMUNOTHERAPY
#18Peptide derived from GPC3, pharmaceutical composition for treatment or prevention of cancer using the same, immunity inducer, and method for producing antigen-presenting cells
#19Tumor targeted TNF-related apoptosis inducing ligand fusion polypeptide, methods and uses therefor
#20Multispecific and multifunctional molecules and uses thereof
#21Immunotherapy for angiogenic disease
#22Peptides, combination of peptides as targets and for use in immunotherapy against gallbladder cancer and cholangiocarcinoma and other cancers
#23H3.3 CTL peptides and uses thereof
#24Multivalent CD20-binding molecule comprising Shiga toxin A subunit effector polypeptides and enriched compositions thereof
#25CTL INDUCER COMPOSITION
#26CEACAM5 PEPTIDES FOR CROHN'S DISEASE
#27Peptides and combination of peptides for use in immunotherapy against breast cancer and other cancers
#28Peptides and combination of peptides for use in immunotherapy against small cell lung cancer and other cancers
#29Selective inhibitors of c-Fos and their antiproliferative properties
#30Methods and compositions for the treatment of cancer
#31Method of inducing an immune response by administering WDRPUH epitope peptides
#32Personalized immunotherapy against several neuronal and brain tumors
#33Method of inducing an immune response by administering WDRPUH epitope peptides
#34Immunotherapeutic method for treating prostate cancer
#35METHOD OF TREATING TUMOR RESISTANT TO HERCEPTIN OR PACLITAXEL USING FOXM1 INHIBITORS AND DETECTING SAME
#36Immunogenic WT-1 peptides and methods of use thereof
#37NY-ESO-1 peptides which bind to class II molecules and uses thereof